Sysmex research into the interdependencies between haematological cell counts and pathologies is helping to make huge advances in delivering clinical insight.

• Know more about your patient's immune response status: the diagnostic extended inflammation parameters support early diagnosis, so that treatment can be started, changed or modified faster.

• Beyond the stem cells count: stem cell detection allows optimisation and management of the stem cell apheresis process and a better patient monitoring throughout the therapy.

• Experience the use of immature platelets: the novel IPF# haematological diagnostic parameter provides valuable information with coronary artery disease, ITP and other thrombocytopenia's.

With the new clinical values treating physicians gain faster, more detailed insight into patients' illnesses and can confidently deliver more effective diagnoses and treatment monitoring.